中国医疗前沿
中國醫療前沿
중국의료전연
CHINA HEALTHCARE INNOVATION
2013年
21期
63-63,88
,共2页
孙智芳%付志勇%管湘霞%万淑华%杨丽萍
孫智芳%付誌勇%管湘霞%萬淑華%楊麗萍
손지방%부지용%관상하%만숙화%양려평
乳腺癌%新辅助化疗%彩色多普勒超声
乳腺癌%新輔助化療%綵色多普勒超聲
유선암%신보조화료%채색다보륵초성
Breast carcinoma%Neoadjuvant chemotherapy%Color Doppler flow imaging
目的:分析彩色多普勒对乳腺癌新辅助化疗疗效。方法随机选取我院乳腺癌患者180例,采取新辅助化疗疗法,利用彩色多普勒观察新辅助化疗前后原发灶、血流分布、动力学参数及二维超声等多项指标,并评价临床疗效。结果180例患者新辅助化疗前原发病灶平均体积12.85±4.26cm3,化疗后原发病灶平均体积4.18±1.52cm3,二者差异有统计学意义(P <0.05);新辅助化疗后,血流分级类型有显著变化(P <0.05)。结论彩色多普勒能客观评价乳腺癌新辅助化疗的疗效,值得临床推广。
目的:分析綵色多普勒對乳腺癌新輔助化療療效。方法隨機選取我院乳腺癌患者180例,採取新輔助化療療法,利用綵色多普勒觀察新輔助化療前後原髮竈、血流分佈、動力學參數及二維超聲等多項指標,併評價臨床療效。結果180例患者新輔助化療前原髮病竈平均體積12.85±4.26cm3,化療後原髮病竈平均體積4.18±1.52cm3,二者差異有統計學意義(P <0.05);新輔助化療後,血流分級類型有顯著變化(P <0.05)。結論綵色多普勒能客觀評價乳腺癌新輔助化療的療效,值得臨床推廣。
목적:분석채색다보륵대유선암신보조화료료효。방법수궤선취아원유선암환자180례,채취신보조화료요법,이용채색다보륵관찰신보조화료전후원발조、혈류분포、동역학삼수급이유초성등다항지표,병평개림상료효。결과180례환자신보조화료전원발병조평균체적12.85±4.26cm3,화료후원발병조평균체적4.18±1.52cm3,이자차이유통계학의의(P <0.05);신보조화료후,혈류분급류형유현저변화(P <0.05)。결론채색다보륵능객관평개유선암신보조화료적료효,치득림상추엄。
Objective To explore Color Doppler Ultrasonography in evaluating effect of neoadjuvant chemotherapy to breast carcinoma. Methods 180 cases of patients recurrently diagnosed with breast carcinoma were randomly selected. The primary tumors and node metastases of 180 patients with breast cancer were evaluated by color Doppler and ultrasonic energy before and after chemotherapy. Result The mean volume of the tumors were 12.85±4.26cm3 and 4.18 ±1.52cm3 before and after chemotherapy(P <0.05), with significant difference. There were significant differences in the blood mode and RI value of the breast tumors between before and after chemotherapy(P <0.05), with significant difference. Conclusion It is useful to appraise the effect of neoadjuvant chemotherapy to breast carcinoma by Color Doppler Uhtrasonography.